You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Von Hippel-Lindau (VHL)

Showing 1 - 25 of 263
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer

Recruiting
  • VHL Pancreatic Neuroendocrine Tumors
  • +2 more
  • 68-Gallium DOTATATE
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Von Hippel-Lindau: Clinical Manifestations, Diagnosis,

Recruiting
  • Kidney Cancer
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    VHL - Von Hippel-Lindau Syndrome, VHL Gene Mutation, VHL Syndrome Trial in Worldwide (Belzutifan)

    Active, not recruiting
    • VHL - Von Hippel-Lindau Syndrome
    • +5 more
    • Bethesda, Maryland
    • +10 more
    Aug 16, 2022

    Von Hippel-Lindau Disease, Genetic Disorder Trial in Boston (3RP-VHL)

    Not yet recruiting
    • Von Hippel-Lindau Disease
    • Genetic Disorder
    • 3RP-VHL
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Feb 10, 2023

    Brain and Spinal Cord Tumor Growth and Cyst Development in Von

    Active, not recruiting
    • Hemangioblastoma
    • Hippel Lindau Disease
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Patients With Von Hippel Lindau Disease

      Not yet recruiting
      • Von Hippel Lindau Disease
        • Houston, Texas
          M D Anderson Cancer Center
        Jul 18, 2023

        Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease Trial in Worldwide (Belzutifan)

        Recruiting
        • Pheochromocytoma/Paraganglioma
        • +2 more
        • Los Angeles, California
        • +58 more
        Jan 27, 2023

        Von Hippel-Lindau Disease, Hereditary Leiomyomatosis and Renal Cell Cancer, Birt-Hogg-Dube Syndrome Trial in Boston

        Recruiting
        • Von Hippel-Lindau Disease
        • +3 more
          • Boston, Massachusetts
            VHL Alliance
          Oct 4, 2021

          Von Hippel-Lindau Disease Trial (68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and

          Not yet recruiting
          • Von Hippel-Lindau Disease
          • 68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and pelvis) 68Ga-NODAGA-LM3 PET/CT (exploratory)
          • (no location specified)
          Mar 30, 2023

          Hemangioblastoma of CNS, Von Hippel-Lindau Disease Trial in Le Kremlin Bicêtre (Propranolol, follow-up)

          Not yet recruiting
          • Hemangioblastoma of CNS
          • Von Hippel-Lindau Disease
          • Le Kremlin Bicêtre, France
            AP-HP, Bicêtre Hospital
          Jun 14, 2022

          Frequency, Clinical Phenotype and Genetic Analysis of Heritable

          Not yet recruiting
          • Renal Tumor Histology
          • +13 more
          • Gene test
          • Shanghai, Shanghai, China
            Ethics Committee of Shanghai Renji Hospital
          Sep 6, 2022

          Von Hippel-Lindau Syndrome Trial run by the NEI (Ranibizumab, E10030)

          Completed
          Has Results
          • Von Hippel-Lindau Syndrome
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Oct 21, 2021

          Von Hippel-Lindau Disease Genetic Epidemiology Study

          Terminated
          • Von Hippel Lindau Disease
          • Kidney Neoplasms
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Jan 9, 2020

            Solid Tumor, Renal Cell Carcinoma, Von Hippel-Lindau Disease Trial in China (BPI-452080)

            Not yet recruiting
            • Solid Tumor
            • +2 more
            • Shanghai, Shanghai, China
            • +4 more
            Apr 24, 2023

            Adenocarcinoma, Prostate Tumors, Prostate Cancer Trial run by the National Institutes of Health Clinical Center (CC) (EM

            Enrolling by invitation
            • Adenocarcinoma
            • +4 more
            • EM Tracking
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Apr 7, 2022

            Hereditary Leiomyomatosis Renal Cell Cancer - Study of Genetic

            Recruiting
            • Renal Tumor Histology
            • +2 more
              • Bethesda, Maryland
                National Institutes of Health Clinical Center
              Dec 28, 2022

              Neuroendocrine Neoplasms Including Adrenocortical Carcinoma

              Recruiting
              • Neuroendocrine Tumors
              • Carcinoma, Neuroendocrine
                • Bethesda, Maryland
                  National Institutes of Health Clinical Center
                Jan 20, 2023

                Familial Investigations of Childhood Cancer Predisposition

                Recruiting
                • Acute Leukemia
                • +45 more
                  • Memphis, Tennessee
                    St. Jude Children's Research Hospital
                  May 11, 2022

                  Polycythemia; Familial, Erythrocytosis; Familial, VHL Gene Mutation Trial (Digoxin)

                  Not yet recruiting
                  • Polycythemia; Familial
                  • +5 more
                  • (no location specified)
                  Feb 2, 2022

                  Neurocutaneous Syndromes in Upper Egypt Children

                  Not yet recruiting
                  • Neurocutaneous Syndromes
                    • (no location specified)
                    Sep 10, 2023

                    Meningioma, Metastatic Well Differentiated Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston (Computed

                    Terminated
                    • Meningioma
                    • +5 more
                    • Computed Tomography
                    • +2 more
                    • Houston, Texas
                      M D Anderson Cancer Center
                    Feb 11, 2021

                    Diabetic Foot Ulcer Trial (Deferoxamine, Placebo)

                    Not yet recruiting
                    • Diabetic Foot Ulcer
                    • (no location specified)
                    May 25, 2022

                    Neuroendocrine Tumors, Von Hippel-Lindau Syndrome, Hippel-Lindau Disease Trial run by the NCI (68Gallium DOTATATE, Radio-guided

                    Completed
                    Has Results
                    • Neuroendocrine Tumors
                    • +2 more
                    • 68Gallium DOTATATE
                    • Radio-guided surgery
                    • Bethesda, Maryland
                      National Institutes of Health Clinical Center
                    Nov 8, 2019

                    Carcinoma, Renal Cell Trial in Worldwide (DFF332, RAD001, PDR001)

                    Recruiting
                    • Carcinoma, Renal Cell
                    • Duarte, California
                    • +10 more
                    Jun 13, 2022

                    Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)

                    Available
                    • Clear Cell Kidney Cancer
                    • +2 more
                    • Axitinib 5 MG
                    • (no location specified)
                    Jul 3, 2023